penicillin v has been researched along with ly 163892 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Disney, FA; Hanfling, MJ; Hausinger, SA | 1 |
| McCarty, J | 1 |
| Kamme, C; Petersson, AC | 1 |
| Larsson, P; Roos, K | 1 |
| Kamme, C; Orrling, A; Stjernquist-Desatnik, A | 1 |
1 review(s) available for penicillin v and ly 163892
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for penicillin v and ly 163892
| Article | Year |
|---|---|
Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis.
Topics: Cephalosporins; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant; Male; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1992 |
Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population.
Topics: Adult; Cephalosporins; Cough; Diarrhea; Double-Blind Method; Headache; Humans; North America; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1992 |
Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis.
Topics: Cephalosporins; Double-Blind Method; Humans; Penicillin V; Penicillins; Pharyngeal Diseases; Streptococcal Infections; Tonsillitis | 1997 |
Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute group A streptococcal pharyngotonsillitis.
Topics: Adult; Aged; Anti-Bacterial Agents; C-Reactive Protein; Cephalosporins; Clindamycin; Female; Humans; Male; Middle Aged; Orosomucoid; Palatine Tonsil; Penicillin V; Streptococcal Infections; Streptococcus pyogenes; Tissue Distribution; Tonsillitis | 2005 |
4 other study(ies) available for penicillin v and ly 163892
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
In vitro effect on group A streptococci of loracarbef versus cefadroxil, cefaclor and penicillin V.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cephalosporins; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1993 |